Diabetes Drug Infection Lawsuit | Lawsuits for Necrotizing Fasciitis

The widely-used diabetes drugs known as SGLT2 inhibitors have been linked to a rare form of flesh-eating genital infection that can result in disfigurement and death. Known as necrotizing fasciitis or Fournier's gangrene, this bacterial infection was the subject of a recent FDA diabetes drug warning. Previous FDA records show this flesh-eating bacterial infection harming only 6 individuals in 30 years, all of them men. In comparison, Type 2 diabetes drugs have been linked to 12 cases in only 5 years' time – 5 of them women. Patients who develop necrotizing fasciitis from SGLT2 inhibitors have required one or more surgeries. Some suffer from permanent disfigurement, and one died.

Thirteen different Type 2 diabetes drugs were included in the FDA diabetes drug infection warning, including products from multinational pharmaceutical conglomerates Janssen / Johnson & Johnson, AstraZeneca, Merck, and Eli Lilly. A brief look into these companies' track records shows consumers have little reason to trust these companies: J&J / Janssen has paid millions in settlements recently over talcum powder claims, for allegedly concealing a known ovarian cancer risk. AstraZeneca paid dearly for incidents of off-label marketing, the production of multiple dangerous drugs, and the fraudulent use of Medicaid funds. Merck paid approximately $6 billion in settlements and criminal fines related to its Vioxx painkiller. And Boehringer Ingelheim / Eli Lilly paid nearly $3 billion in criminal fines and payouts related to a decade-long coverup related to a schizophrenia drug. Bloomberg projects SGLT2 diabetes drug sales will reach $7 billion by 2020, and each of these companies is vying for a competitive edge in the market.

Now drug companies are facing serious questions about their prior knowledge of the risk for necrotizing fasciitis from diabetes drugs. Persons and the family members of persons who have suffered from the effects of flesh-eating genital infections from diabetes drugs are filing diabetes drug infection lawsuits against AstraZeneca, Janssen, Eli Lilly, and Merck. Filing a diabetes drug infection lawsuit is the only means individuals and families have to obtain the compensation they deserve for suffering, damage, medical expenses and loss related to the flesh-eating genital infection known as Fournier's gangrene or necrotizing fasciitis. In addition, filing a diabetes drug genital infection lawsuit claim is the best method for individual consumers to hold manufacturers accountable for the safety of its drugs.